Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Special issues
    • Subject collections
    • Cell Scientists to Watch
    • First Person
    • Sign up for alerts
  • About us
    • About JCS
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Fast-track manuscripts
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • JCS Prize
    • Manuscript transfer network
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contacts
    • Contact JCS
    • Subscriptions
    • Advertising
    • Feedback
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

User menu

  • Log in

Search

  • Advanced search
Journal of Cell Science
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

supporting biologistsinspiring biology

Journal of Cell Science

  • Log in
Advanced search

RSS   Twitter  Facebook   YouTube  

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Special issues
    • Subject collections
    • Cell Scientists to Watch
    • First Person
    • Sign up for alerts
  • About us
    • About JCS
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Fast-track manuscripts
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • JCS Prize
    • Manuscript transfer network
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contacts
    • Contact JCS
    • Subscriptions
    • Advertising
    • Feedback
Research Article
ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth
Akira Motegi, Jiro Fujimoto, Masaharu Kotani, Hitoshi Sakuraba, Tadashi Yamamoto
Journal of Cell Science 2004 117: 3319-3329; doi: 10.1242/jcs.01183
Akira Motegi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiro Fujimoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masaharu Kotani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hitoshi Sakuraba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tadashi Yamamoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & tables
  • Info & metrics
  • PDF
Loading

Article Figures & Tables

Figures

  •   Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Characterization of anti-ALK monoclonal antibody. (A) Preparation of immunogen (APmH). The entire extracellular domain (ECD) of mouse ALK (ALK) followed by a PreScission protease site and a myc-His tag (PmH) was expressed and collected as described in Materials and Methods. The ECD of ALK fused with the Fc portion of human immunoglobulin (ALK-Fc) was used as an antigen for ELISA screening. Abbreviations: SS, signal sequence; TM, transmembrane domain; PTK, protein tyrosine kinase domain. (B) HEK 293T cells were transfected with APmH-expressing vector (+) and the recombinant protein was collected on the chelating Sepharose, separated by SDS-PAGE, and transferred to PVDF membranes for immunoblotting. Supernatant from cells transfected with empty vector was treated in the same way as a negative control (–). The membranes were blotted with either anti-myc (myc) or anti-ALK monoclonal (mAb16-39) antibodies (2 μg/ml). (C) APmH protein was immunoprecipitated with anti-myc antibody (myc), mAb16-39 (16-39), or normal rat IgG (IgG) (2 μg each). As a control, the APmH protein was collected by the chelating Sepharose (HIS), which allowing the purification of the recombinant protein through binding to the His tag epitope. Immunoprecipitated proteins were probed with anti-myc antibody 9E10 (myc).

  •   Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Monoclonal anti-ALK antibody 16-39 induces tyrosine phosphorylation of ALK. Untransfected NIH 3T3 cells (NIH), derivative cells expressing mouse ALK (2-C4), or human neuroblastoma cells SK-N-SH (SK) were treated with 20 nM normal rat IgG (–) or mAb16-39 (+) for 5 minutes at 37°C. Lysates were immunoprecipitated with polyclonal anti-ALK antibodies that recognize the carboxyl terminus of ALK. The phosphotyrosine level was examined by western blotting (Blot) with anti-PY antibody RC20-HRP (upper panels). The presence of equal amounts of ALK was confirmed by reprobing with polyclonal anti-ALK antibodies (lower panels). Arrowheads indicate the positions of endogenous and transfected ALK (220, 140, and 85 kDa in 2-C4 cells and 220 and 140 kDa in SK-N-SH cells). The bracket shows the position of phosphoproteins of 66, 52, and 46 kDa in both 2-C4 and SK-N-SH cells. Asterisks indicate phosphoproteins of 160, 120, 85, and 35 kDa in SK-N-SH cells.

  •   Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Dose-response (A) and time course (B) of ALK tyrosine phosphorylation in 2-C4 cells. For dose-response analysis, 2-C4 cells were treated with increasing concentrations of mAb16-39 (0, 0.12, 0.4, 1.2, 4, 12, 40, and 120 nM) for 5 minutes at 37°C. As a contr ol, parental NIH 3T3 cells were treated with 12 nM mAb for 5 minutes. For time-course analysis, cells were incubated with 4 nM mAb16-39 for the periods indicated (0, 2, 5, 15, 60, and 180 minutes and 24 hours). As controls, 2-C4 or parental NIH 3T3 cells were treated with 4 nM control IgG for 24 hours or 4 nM mAb for 5 minutes, respectively. ALK immunoprecipitates were probed with anti-PY antibody RC20-HRP (PY) and then reprobed with anti-ALK antibodies (ALK). The positions of 220-, 140-, and 85-kDa ALK bands are indicated by arrowheads.

  •   Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Analysis of downstream signaling. (A) Serum-starved SK-N-SH cells were stimulated with 4 nM anti-ALK mAb16-39 for 5 minutes. Lysates were immunoprecipitated (IP) with anti-ALK (ALK) or anti-Shc (Shc) antibodies or were immunoprecipitated without antibodies (mock) and immunoblotted with anti-PY antibody (upper panels). The same blots were reprobed with anti-ALK (middle panels) or anti-Shc (lower panels) antibodies. The positions of ALK (220 and 140 kDa) and three isoforms of Shc (66, 52, and 44 kDa) are indicated by the arrowheads and bracket, respectively. The dot shows the position of Shc (66 kDa). (B,C,D,E) Lysates prepared as above were immunoprecipitated with antibodies as indicated and immunoblotted with anti-PY antibody (upper panels) and then reprobed with the indicated antibodies (lower panels). The positions of the immunoprecipitated proteins are indicated by dots. Asterisks in C show unidentified co-immunoprecipitated proteins with anti-p85 antibody.

  •   Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Effects of mAb16-39 on DNA synthesis. Serum-deprived 2-C4, parental NIH 3T3 (A), or SK-N-SH (B) cells were cultured for 2 days in the presence of various concentrations (nM) of normal rat IgG, mAb16-39, NGF, or 5% serum as indicated. (–) in the serum column indicates 0.1% serum. [3H]thymidine uptake over the last 4 hours of culture was measured and is presented as the mean±s.e.m. of three experiments performed in duplicate.

  •   Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Mitogenic properties of mAb16-39 are dependent on ERK activity. (A) Effect of mAb16-39 on ERK activation. 2-C4 cells were serum starved for 24 hours and treated with 4 nM normal rat IgG (–) or mAb16-39 (+) for 5 minutes or 3 hours. Equal amounts of total cell lysate were probed with phospho-specific anti-ERK1/2 antibody (ERK1/2-P). The blots were stripped and reprobed with anti-ERK antibody (ERK2). (B) Quantification of data presented in A. The intensity of the bands in the anti-phospho-ERK1/2 blot was normalized against the amounts of MAPK and expressed as fold activation over basal levels (IgG-treated). (C) Effect of the MEK inhibitor PD98059 on the mitogenic activity induced by mAb16-39. Serum-deprived 2-C4 cells were left untreated or were treated with 4 nM IgG or mAb16-39 for 2 days in the presence or absence of PD98059 (50 μM) or wortmannin (100 nM). [3H]thymidine uptake assay was performed as in Fig. 5, and the data are presented as the mean±s.e.m.

  •   Fig. 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 7.

    mAb16-39 induces neurite outgrowth in an ERK-dependent manner. SK-N-SH cells were cultured in insulin, transferrin and selenium-supplemented media in the presence of mAb16-39 (4 nM), control normal rat IgG (4 nM), or NGF (2 nM) and photographed at day 2.5. Treatment of cells with mAb16-39 (C) resulted in extensive outgrowth of long neurites and increased cell number. Similar but less significant effects were observed in cells treated with NGF (B). Cells treated with control IgG (A) showed no significant effect on morphology. Neurite extension induced by mAb16-39 was efficiently blocked by the MEK inhibitor PD98059 (50 μM) (D). Scale bar, 50 μm. (E) Cell differentiation was scored as described in Materials and Methods and expressed as the mean±s.e.m. (%).

Previous ArticleNext Article
Back to top
Previous ArticleNext Article

This Issue

 Download PDF

Email

Thank you for your interest in spreading the word on Journal of Cell Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth
(Your Name) has sent you a message from Journal of Cell Science
(Your Name) thought you would like to see the Journal of Cell Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Research Article
ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth
Akira Motegi, Jiro Fujimoto, Masaharu Kotani, Hitoshi Sakuraba, Tadashi Yamamoto
Journal of Cell Science 2004 117: 3319-3329; doi: 10.1242/jcs.01183
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Research Article
ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth
Akira Motegi, Jiro Fujimoto, Masaharu Kotani, Hitoshi Sakuraba, Tadashi Yamamoto
Journal of Cell Science 2004 117: 3319-3329; doi: 10.1242/jcs.01183

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Alerts

Please log in to add an alert for this article.

Sign in to email alerts with your email address

Article navigation

  • Top
  • Article
    • Summary
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • References
  • Figures & tables
  • Info & metrics
  • PDF

Related articles

Cited by...

More in this TOC section

  • EFA6A, an exchange factor for Arf6, regulates early steps in ciliogenesis
  • SetDB1 and Su(var)3-9 play non-overlapping roles in somatic cell chromosomes of Drosophila melanogaster
  • p.E152K-STIM1 mutation deregulates Ca2+ signaling contributing to chronic pancreatitis
Show more RESEARCH ARTICLE

Similar articles

Other journals from The Company of Biologists

Development

Journal of Experimental Biology

Disease Models & Mechanisms

Biology Open

Advertisement

2020 at The Company of Biologists

Despite the challenges of 2020, we were able to bring a number of long-term projects and new ventures to fruition. While we look forward to a new year, join us as we reflect on the triumphs of the last 12 months.


Mole – The Corona Files

"This is not going to go away, 'like a miracle.' We have to do magic. And I know we can."

Mole continues to offer his wise words to researchers on how to manage during the COVID-19 pandemic.


Cell scientist to watch – Christine Faulkner

In an interview, Christine Faulkner talks about where her interest in plant science began, how she found the transition between Australia and the UK, and shares her thoughts on virtual conferences.


Read & Publish participation extends worldwide

“The clear advantages are rapid and efficient exposure and easy access to my article around the world. I believe it is great to have this publishing option in fast-growing fields in biomedical research.”

Dr Jaceques Behmoaras (Imperial College London) shares his experience of publishing Open Access as part of our growing Read & Publish initiative. We now have over 60 institutions in 12 countries taking part – find out more and view our full list of participating institutions.


JCS and COVID-19

For more information on measures Journal of Cell Science is taking to support the community during the COVID-19 pandemic, please see here.

If you have any questions or concerns, please do not hestiate to contact the Editorial Office.

Articles

  • Accepted manuscripts
  • Issue in progress
  • Latest complete issue
  • Issue archive
  • Archive by article type
  • Special issues
  • Subject collections
  • Interviews
  • Sign up for alerts

About us

  • About Journal of Cell Science
  • Editors and Board
  • Editor biographies
  • Travelling Fellowships
  • Grants and funding
  • Journal Meetings
  • Workshops
  • The Company of Biologists

For Authors

  • Submit a manuscript
  • Aims and scope
  • Presubmission enquiries
  • Fast-track manuscripts
  • Article types
  • Manuscript preparation
  • Cover suggestions
  • Editorial process
  • Promoting your paper
  • Open Access
  • JCS Prize
  • Manuscript transfer network
  • Biology Open transfer

Journal Info

  • Journal policies
  • Rights and permissions
  • Media policies
  • Reviewer guide
  • Sign up for alerts

Contacts

  • Contact JCS
  • Subscriptions
  • Advertising
  • Feedback

Twitter   YouTube   LinkedIn

© 2021   The Company of Biologists Ltd   Registered Charity 277992